Biogen第一季度营收24.3亿美元超预期

DoNews
01 May

生物技术公司Biogen公布2023年第一季度财报,营收达24.3亿美元,同比增长6.2%,高于市场预估的22.3亿美元。调整后每股收益为3.02美元,较上年同期的3.67美元有所下降。同期调整后净利润为4.432亿美元。尽管每股收益下滑,但整体业绩仍超出分析师预期。免责声明:本文内容由开放的智能模型自动生成,仅供参考。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10